ArticleJournal of experimental & clinical cancer research : CR2024

Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia.

Tongting Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.